Category Archives: Press Releases

Home / Archive by category "Press Releases"

Press Releases

VirMedica Announces Opening of New Corporate Office

Strong Demand for eAccess Technology Solutions Spurs Expansion in Boston
 
October 11, 2016 – Boston, MA – VirMedica, the leader in providing e-access technology solutions designed to expedite patient access to biopharmaceutical products, today announced that the Company has opened a new corporate office in Boston, Massachusetts. The Company also maintains an office in Shelton, Connecticut.
 
“Given the increasing demand for new technologies in the patient access market, we have decided to accelerate our hiring and subsequently are expanding our office space,” said Philip Lee, president and chief executive officer of VirMedica. “Boston, with its high concentration of biotechnology companies, top-tier academic institutions and rich talent base, offers an ideal fit with VirMedica’s mission to develop technologies to transform patient access services for specialty therapies.”
 
VirMedica’s e-access technology portfolio features the industry’s most advanced medical electronic benefit verification and workflow automation tools, a robust provider-facing portal configured around the needs of office-based injectables and e-services tools designed to automate the prior authorization process for therapies covered under a pharmacy benefit. VirMedica’s corporate office is located at 186 Lincoln Street in Boston, Massachusetts.

Press Releases

VirMedica Expands Senior Leadership Team to Support Company Growth

June 8, 2016 – Boston, MA – VirMedica, the leader in providing e-access and specialty pharmacy technology solutions designed to expedite patient access to biopharmaceutical products, today announced the appointment of three new executives to the Company’s senior leadership team. John J. Arcari has been appointed to chief financial officer (CFO) and will oversee the Company’s financial operations. Richard Deyermond joins the company as vice president of client services and will lead teams engaged in the delivery of VirMedica’s technology solutions. As the vice president of engineering, Elizabeth Ricci will focus on building out the Company’s technology suite. These executives will report directly to Philip Lee, president and chief executive officer of VirMedica, and will be located at the Company’s Boston office.

“We are pleased to welcome John, Richard and Elizabeth to the VirMedica team,” said Philip Lee, president and chief executive officer of VirMedica. “We are committed to hiring the best talent in the business to advance our technologies and deliver real value to our customers. Their collective experience, world-class leadership and deep industry expertise will be instrumental in building out the organization and executing upon our vision to transform the patient access ecosystem for biopharmaceutical products and extending RxVector, our specialty pharmacy management system. To accommodate business growth, we are also expanding our workforce significantly over the next few months.”

John Arcari’s professional tenure spans more than 30 years and includes expertise in profitability enhancement, mergers and acquisitions and financial management. Most recently, John served as an engagement partner for Tatum, a Boston-based executive services firm. Prior to that, John served as the CFO of PHT Corporation, a leading provider of electronic clinical outcome assessment systems. Previous engagements include CFO positions at CRF, Inc., Organogenesis, Inc. and Intl.com. John is a registered Certified Public Accountant in the state of Massachusetts and holds a MBA from New Mexico State University.

Richard Deyermond brings more than 30 years of leadership experience in SaaS and cloud-based software operations. Most recently, Richard served as senior vice president at Global Service Delivery, Data Intensity, a leading supplier of cloud-based and remote managed solutions for the Oracle suite. Prior to Data Intensity, Richard was vice president (VP) of product support/cloud enablement for Oracle, where he was responsible for global customer support for Oracle’s HSGBU (Health Sciences Global Business Unit). Previous to that, he was VP of customer operations at Phase Forward, which was acquired by Oracle in 2010. While at Phase Forward, Richard was responsible for all infrastructure and SaaS operations, along with global support and customer care engagement management teams supporting several leading international pharmaceutical and biotechnology companies. Richard received his B.S. in Business Administration from Fitchburg State College and his MBA from Northeastern University.

With more than 30 years in the computer software industry, Elizabeth Ricci joins VirMedica as an accomplished global software executive with a proven track record in engineering, project management and product development, with an emphasis on quality, timeliness and customer success. In her prior engagement as VP of engineering for PHT Corporation, she was responsible for all core products and was instrumental in rolling out the company’s next generation technologies. Prior positions include senior VP, products at Kadient, Inc., and senior VP, global products at Authoria, Inc. Elizabeth holds a B.A. in Mathematics from Rutgers University and a M.S. in Mathematics from Northeastern University.

About VirMedica
VirMedica is the industry leader in providing e-access technology solutions designed to expedite patient access to biopharmaceutical products. The company is also a leader in providing specialty pharmacy management solutions. VirMedica’s proprietary platforms are transforming the market access landscape for biopharmaceutical products through simplifying, automating and ultimately accelerating many pre-treatment processes required of patients and their providers. For more information about VirMedica and its portfolio of proprietary e-access technology solutions, please visit: http://virmedica.com/.

Press Releases

VirMedica Announces Launch of eAccessRx to Help Automate and Simplify Provider Workflows for Biopharmaceutical Products

May 2, 2016 – Philadelphia, Pa. – VirMedica, the leader in providing e-access technology solutions designed to expedite patient access to biopharmaceutical products, today announced the launch of eAccessRx, a patient onboarding solution designed to streamline provider workflows for treatments that typically require a Prior Authorization and are covered under a patient’s pharmacy benefit. eAccessRx adds to VirMedica’s growing portfolio of proprietary technology solutions, branded under the name eAccess, which help simplify and automate the steps necessary for patients and their providers to initiate and adhere to treatment.

“The addition of eAccessRx to VirMedica’s solutions portfolio represents another significant milestone in our pursuit to help patients and their physicians simplify and accelerate the pathway to life-enhancing treatments. By automating cumbersome workflows and delivering real-time benefit and formulary information, providers can now complete pre-treatment steps and address payer requirements in minutes instead of days,” said Philip Lee, president and chief executive officer of VirMedica. “The launch of eAccessRx is further evidence of our commitment to providing proprietary technologies that fundamentally transform the way that patients access treatment.”

eAccessRx offers providers the ability to easily navigate benefits investigations, comply with Prior Authorization requirements, complete manufacturer enrollment forms and track prescription progress. The solution is highly adaptable, scalable and secure, and can be delivered as either a provider portal or as a Hub call center utility as follows:

• eAccessRx Provider is a patient onboarding solution designed to streamline access workflows and help the provider determine which specialty pharmacy is authorized to fill a prescription. Case status updates are also delivered back to the provider and convenient e-tools are available to capture patient consent and manufacturer enrollment forms.

• eAccessRx Transact is a HUB call center utility that provides instant access to VirMedica’s proprietary electronic benefit investigation and electronic Prior Authorization capabilities.

“The complexity and diversity of the U.S. healthcare system can be challenging for patients and providers. VirMedica’s eAccessRx technology helps manufacturers create a better customer experience, one that ensures a patient has access to services and potentially life-enhancing treatments quickly and efficiently,” said Gregory R. Morris, chief commercial officer of VirMedica. “The industry is moving away from manual legacy processes and embracing new e-access technologies that streamline workflows, lower administrative costs and improve overall patient access outcomes. We are excited to be a leader in transforming the patient access marketplace.”

About VirMedica
VirMedica is the industry leader in providing e-access technology solutions designed to expedite the patient onboarding process for biopharmaceutical products. VirMedica’s proprietary platforms are transforming the market access landscape for biopharmaceutical products through simplifying, automating and ultimately accelerating many pre-treatment processes required of patients and their providers. For more information about VirMedica and its portfolio of proprietary e-access technology solutions, please visit: http://virmedica.com/.

Press Releases

VirMedica Board of Directors Appoints Industry Veteran Philip Lee as President and Chief Executive Officer

 

April 11, 2016 – Philadelphia, Pa. – VirMedica, the leader in providing e-access technology solutions designed to expedite patient access to biopharmaceutical products, today announced that its Board of Directors has appointed Philip Lee as president, chief executive officer (CEO) and a member of the Board of Directors, effective immediately.

 

“As we enter an important growth stage for VirMedica, the Board of Directors welcomes Phil’s impressive leadership and industry experience along with his passion and proven success driving corporate performance in the healthcare arena,” said John H. Johnson, chairman of VirMedica. “In his role as president and CEO, Phil will be responsible for advancing VirMedica’s proprietary e-access technology, extending our track record of innovation and delivering upon our core mission to expedite the patient journey to potentially life-enhancing biopharmaceutical products,” Johnson added.

 

Mr. Lee is a seasoned industry leader with more than 35 years of executive management and leadership experience across a wide range of enterprise solutions for Fortune 1000 clients. He has spent the past two decades driving innovation and accelerating drug development for the life sciences industry. Mr. Lee most recently served as president and chief executive officer of PHT Corporation, a leading provider of electronic clinical outcome assessments solutions for the biopharmaceutical industry, which was acquired in 2015 by ERT, a leading provider of patient data collection services. Mr. Lee’s prior executive management positions included serving as president of eXcelon Corporation and as president and CEO of Clinsoft. Earlier in his career, Mr. Lee held roles of increasing responsibility at Bolt, Beranek & Neumann, Interleaf, Inc., Oracle Corporation and Digital Equipment Corporation. Mr. Lee was named Ernst & Young ‘Entrepreneur of the Year’ finalist in 2012 and 2013, one of PharmaVoice’s ‘100 Most Inspirational People in Life Sciences’ and as a ‘Tech Luminary of the Year’ by Mass High Tech and The Boston Business Journal in 2012. Mr. Lee earned a B.S. in Operations Research and Industrial Engineering and a Master of Engineering degree from Cornell University.

 

“The industry faces unprecedented opportunities and challenges posed by the increasingly complex patient access landscape. There is tremendous demand for technology solutions that can simplify the often-complicated path that providers and their patients must navigate prior to accessing treatment. I look forward to working closely with John, the Board of Directors and management team to further transform the patient access ecosystem, grow VirMedica’s business across all segments of the Company’s enterprise and to better serve our customers and ultimately patients,” said Philip Lee, president and chief executive officer of VirMedica.

 

About VirMedica

VirMedica is the industry leader in providing e-access technology solutions designed to expedite patient access to potentially life-enhancing biopharmaceutical products. VirMedica’s proprietary e-access platforms are transforming the market access landscape for biopharmaceutical products through simplifying, automating and ultimately accelerating many processes for patients and providers within the market access ecosystem.

 

Contacts:

 

Corporate & Media Relations

 

Stephen J. Henricks

VP, Marketing

Shenricks@virmedica.com

+1 203-840-6817

 

Lindsay M. Rocco

Elixir Health Public Relations

lrocco@elixirhealthpr.com

+1 862-596-1304

 

 

Press Releases

VirMedica to Present at CBI’s 6th HUB and SPP Model Optimization Conference

February 22, 2016 – Philadelphia, Pa. – VirMedica, the leader in providing e-access technology solutions designed to expedite patient access to biopharmaceutical products, today announced that the Company will be participating in CBI’s 6th HUB and SPP Model Optimization Conference.
 

CBI’s Hub Model Conference Series brings together esteemed leaders in patient access, brand management, reimbursement and specialty distribution across the healthcare industry and focuses on breakthrough strategies and service model design and enhancement to improve access and outcomes.
 

read more…

Press Release

 John H. Johnson appointed as Executive Chairman of the Board

November 9, 2015 – Philadelphia, Pa. – VirMedica, the leader in providing e-access technology solutions, announced the appointment of John H. Johnson as executive chairman.

John H. Johnson is a recognized leader in the biopharmaceutical industry with more than 30 years of experience at leading global organizations, including Johnson & Johnson, Eli Lilly & Company, ImClone and Pfizer, Inc. He currently serves as chairman of Strongbridge Biopharma plc, and as a member of the board of directors of Cempra Pharmaceuticals, Inc., Histogenics Corporation, Portola Pharmaceuticals, Inc., and Sucampo Pharmaceuticals, Inc. He previously served as a member of the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA), the Health Section Governing Board of Biotechnology Industry Organizations (BIO), and BioNJ.
read more…

Press Release

VirMedica Makes Capital Investment in D2 Pharma Consulting

February 19, 2015 – Philadelphia, PA – VirMedica, a leading provider of technology solutions designed to optimize the commercialization of specialty pharmaceutical products, announced today that it has made a significant capital investment in D2 Pharma Consulting, LLC (“D2”). D2 is an independent consulting firm offering a broad range of commercialization services for manufacturers and service providers in the life sciences industry.

read more…

Press Release

VirMedica Continues to Expand Capabilities through Acquiring Assets of TransEngen, Inc.

February 19, 2015 – Philadelphia, PA. – VirMedica, a leading provider of technology solutions designed to optimize the commercialization of specialty pharmaceutical products, announced today that VirMedica, Inc. (“VirMedica”) has acquired the assets of TransEngen, Inc.

read more…